Chemistry of Contrast Media — MCQs

10 questions

Which of the following typically results in the maximum radiation exposure?

Which of the following contrast agents is PREFERRED in a patient with renal dysfunction for the prevention of contrast-induced nephropathy?

Which radionuclide is best suited for measuring glomerular filtration rate (GFR)?

Which of the following is an example of a low-osmolar ionic contrast agent?

The calculation of Hounsfield units primarily depends on -

GFR for assessment of impaired renal function is best measured by

Which contrast agent is not used for CT scans?

All of the following dyes are water soluble except:

Which of the following is a non-ionic contrast agent?

Q10

To obtain adequate diagnostic imaging in a morbidly obese patient, what modification to X-ray technique is most important?

Chemistry of Contrast Media Indian Medical PG Practice Questions and MCQs

Question 1: Which of the following typically results in the maximum radiation exposure?

A. Chest X ray
B. IV pyelography
C. PET CT (Correct Answer)
D. Barium Enema
E. X-ray abdomen

Explanation: ***PET CT*** - **PET CT (Positron Emission Tomography-Computed Tomography)** combines the radiation from both a PET scan (using radiotracers like FDG) and a CT scan, resulting in the highest typical radiation exposure among the listed options. - The integration of functional (PET) and anatomical (CT) imaging, while providing comprehensive diagnostic information, significantly increases the total absorbed dose (~20-30 mSv). *Chest X-ray* - A **chest X-ray** involves a very low dose of radiation (~0.1 mSv), making it one of the imaging modalities with the least radiation exposure. - Due to its low dose and widespread use, the benefits of chest X-rays in diagnosing pulmonary and cardiac conditions far outweigh the minimal radiation risk. *IV pyelography* - **Intravenous pyelography (IVP)**, or intravenous urography, uses X-rays and contrast dye to visualize the urinary tract, delivering a moderate radiation dose (~3-5 mSv). - While higher than a standard X-ray, its dose is significantly lower than that of complex combined imaging like PET-CT. *Barium Enema* - A **barium enema** involves multiple X-ray images of the large intestine after administering barium contrast, leading to a moderate to high radiation dose (~8-15 mSv). - The series of exposures required to adequately visualize the entire colon contributes to a higher cumulative dose compared to single-shot X-rays.

Question 2: Which of the following contrast agents is PREFERRED in a patient with renal dysfunction for the prevention of contrast-induced nephropathy?

A. Iso-osmolar contrast (Correct Answer)
B. High osmolar contrast
C. Ionic contrast
D. Low osmolar contrast

Explanation: ***Iso-osmolar contrast*** - **Iso-osmolar contrast agents** (e.g., iodixanol) have an osmolality of ~290 mOsm/kg, which is identical to that of plasma. - **This is the PREFERRED choice** in patients with renal dysfunction as multiple studies demonstrate the lowest risk of contrast-induced nephropathy (CIN). - The iso-osmolar formulation minimizes osmotic stress on renal tubules and reduces the risk of acute kidney injury. - **Current guidelines recommend iso-osmolar agents as first-line** in high-risk patients with pre-existing renal impairment. *Low osmolar contrast* - **Low osmolar contrast agents** have osmolality of 600-900 mOsm/kg, which is significantly lower than high osmolar agents but still 2-3 times higher than plasma. - While **acceptable and safer than high osmolar agents**, they are not as optimal as iso-osmolar contrast for patients with renal dysfunction. - These agents are widely used and represent a reasonable alternative when iso-osmolar agents are not available. *High osmolar contrast* - **High osmolar contrast agents** have osmolality >1400 mOsm/kg (about 5 times that of plasma). - They carry the **highest risk of contrast-induced nephropathy** due to severe osmotic load and direct tubular toxicity. - **Contraindicated or strongly avoided** in patients with pre-existing renal dysfunction. *Ionic contrast* - **Ionic contrast** refers to the chemical structure (dissociates into ions) rather than osmolality. - Can be either high or low osmolar—the ionic nature alone does not determine renal safety. - The critical factor for nephrotoxicity prevention is osmolality, not ionic charge.

Question 3: Which radionuclide is best suited for measuring glomerular filtration rate (GFR)?

A. DTPA (Correct Answer)
B. DMSA
C. EDTA
D. Ortho-Iodohippurate

Explanation: ***DTPA*** - **DTPA (⁹⁹ᵐTc-DTPA)** is cleared almost exclusively by **glomerular filtration**, making it an excellent marker for GFR measurement. - Its rapid plasma clearance correlates well with **inulin clearance**, which is the gold standard for GFR. - **⁹⁹ᵐTc labeling** provides superior imaging properties, ready availability from generators, and optimal gamma energy for detection. *DMSA* - **DMSA (⁹⁹ᵐTc-dimercaptosuccinic acid)** primarily binds to the **renal cortex** and is used to assess renal parenchymal function and anatomy. - It does not accurately reflect GFR because it is mainly handled by **tubular uptake**, not glomerular filtration. *Ortho-Iodohippurate* - **Ortho-Iodohippurate (¹³¹I-OIH or ⁹⁹ᵐTc-MAG3)** is predominantly cleared by **tubular secretion**, making it a good measure of **effective renal plasma flow (ERPF)**. - While it provides information on renal function, it is not suitable for direct GFR assessment. *EDTA* - **EDTA (⁵¹Cr-EDTA)** is also cleared by glomerular filtration and can accurately measure GFR, particularly used in Europe. - However, **DTPA is preferred** due to the advantages of **⁹⁹ᵐTc labeling** (better availability, imaging properties, and lower radiation dose) compared to **⁵¹Cr labeling**. - Both are valid GFR markers, but DTPA is more commonly used in routine clinical practice.

Question 4: Which of the following is an example of a low-osmolar ionic contrast agent?

A. Iothalamate
B. Ioxaglate (Correct Answer)
C. Iohexol
D. None of the options

Explanation: ***Ioxaglate*** - **Ioxaglate** is a **low-osmolar ionic dimer**, making it the correct answer to this question. - It dissociates into two iodine-bearing anions and one meglumine/sodium cation in solution. - Its dimeric structure carries six iodine atoms per molecule, and its ionic nature combined with low osmolarity distinguishes it from high-osmolar ionic agents. *Iothalamate* - **Iothalamate** is a **high-osmolar ionic monomer** contrast agent, not low-osmolar. - While it is ionic, it dissociates into one iodine-bearing anion and one meglumine/sodium cation (3 iodine atoms per molecule), resulting in higher osmolarity. - This makes it incorrect for this specific question about low-osmolar agents. *Iohexol* - **Iohexol** is a **non-ionic monomer** contrast agent. - It does not dissociate in solution, remaining as a neutral molecule with three iodine atoms per molecule. - While it is low-osmolar, it is non-ionic, not ionic. *None of the options* - This option is incorrect because **Ioxaglate** is indeed an example of a low-osmolar ionic contrast agent. - Low-osmolar ionic agents like Ioxaglate provide better tolerability compared to high-osmolar ionic agents while maintaining ionic properties.

Question 5: The calculation of Hounsfield units primarily depends on -

A. Attenuation coefficient of the material (Correct Answer)
B. Mass density of the material
C. Effective atomic number of the material
D. Electron density of the material

Explanation: ***Attenuation coefficient of the material*** - Hounsfield units (HU) are **calculated directly from the linear attenuation coefficient (μ)** of the material being scanned. - The formula is: **HU = 1000 × (μ_tissue - μ_water) / (μ_water - μ_air)** - CT scanners measure X-ray attenuation through tissues, and the HU values are derived by comparing the measured attenuation coefficient to that of water (which is assigned 0 HU) and air (assigned -1000 HU). - This is the **primary and direct parameter** used in HU calculation. *Electron density of the material* - While electron density is an **important factor that influences** the attenuation coefficient, it is not directly used in the HU calculation formula. - At CT imaging energies (typically 70-140 keV), Compton scattering predominates, which is dependent on electron density. - However, the relationship is indirect: electron density → affects attenuation coefficient → attenuation coefficient used to calculate HU. *Mass density of the material* - Mass density (ρ) contributes to the attenuation coefficient through the relationship: **μ = ρ × (μ/ρ)**, where (μ/ρ) is the mass attenuation coefficient. - Like electron density, this is an **underlying physical property** that influences attenuation but is not the direct parameter in the HU formula. *Effective atomic number of the material* - Effective atomic number (Z_eff) primarily affects **photoelectric absorption**, which dominates at lower X-ray energies. - At CT energies, photoelectric effect has minimal contribution compared to Compton scattering. - This parameter has **indirect influence** on the attenuation coefficient and therefore on HU values.

Question 6: GFR for assessment of impaired renal function is best measured by

A. MAG3
B. IodoHippurate
C. DTPA (Correct Answer)
D. DMSA Scan

Explanation: ***DTPA*** - **Diethylene Triamine Pentaacetic Acid (DTPA)** is the primary radiopharmaceutical used to measure **glomerular filtration rate (GFR)**, which is the gold standard for quantifying renal function. - DTPA is freely filtered by the glomeruli and not reabsorbed or secreted by the tubules, making it an excellent tracer for evaluating glomerular function and assessing the degree of renal impairment. - **Note:** While MAG3 is often preferred for dynamic renal imaging in patients with severe renal impairment (GFR < 30 ml/min) due to better image quality, DTPA remains the standard for direct GFR measurement. *MAG3* - **Mercaptoacetyltriglycine (MAG3)** is used to assess **effective renal plasma flow (ERPF)** and tubular secretion, not GFR. - MAG3 is actually preferred over DTPA for dynamic renal scintigraphy in patients with poor renal function because of its superior extraction efficiency and image quality. - However, it does not directly measure GFR, which is the primary parameter for quantifying impaired renal function. *IodoHippurate* - **IodoHippurate** (I-123 or I-131 labeled) is used to measure **effective renal plasma flow (ERPF)** through tubular secretion. - While it provides information about renal blood flow, it does not directly measure GFR and is not the primary agent for assessing the degree of renal functional impairment. *DMSA Scan* - **Dimercaptosuccinic acid (DMSA)** is used for **static cortical imaging** to assess renal parenchymal structure and detect abnormalities like renal scarring, differential renal function, or pyelonephritis. - DMSA binds to the proximal tubular cells and provides anatomical information, but does not assess dynamic renal function or measure GFR.

Question 7: Which contrast agent is not used for CT scans?

A. CO2 (Correct Answer)
B. Iodinated high-osmolality contrast media
C. Barium compounds
D. Gadolinium-based contrast agents

Explanation: ***CO2*** - **CO2** (carbon dioxide) is **not used as a contrast agent in CT scans**. - CO2 is primarily used in **angiography** (especially for peripheral vessels in patients with iodine allergy or renal insufficiency) where it acts as a negative contrast agent. - In CT, CO2 would appear as air/gas density and create artifacts rather than providing diagnostic enhancement, making it unsuitable for routine CT imaging. *Iodinated high-osmolality contrast media* - These are **iodinated contrast agents** that contain iodine atoms which strongly attenuate X-rays, making them highly effective for **CT imaging**. - High-osmolality contrast media (HOCM) like **diatrizoate** and **iothalamate** were the standard CT contrast agents historically. - They have largely been replaced by **low-osmolality** and **iso-osmolality** agents due to higher incidence of **adverse reactions**, but they are still used for CT scans. *Barium compounds* - **Barium sulfate** suspensions are widely used as **oral or rectal contrast agents** for CT imaging of the gastrointestinal tract. - Barium has high atomic number and effectively attenuates X-rays, making the **GI lumen clearly visible** on CT scans. - Used in **CT enterography**, **CT colonography**, and routine **abdominal/pelvic CT** protocols. *Gadolinium-based contrast agents* - **Gadolinium-based contrast agents (GBCAs)** are primarily designed for **MRI** due to their **paramagnetic properties**. - However, gadolinium DOES attenuate X-rays and can be used **off-label for CT** in patients with **severe iodine allergy** or **contraindications to iodinated contrast**. - While less effective than iodinated agents for CT (requiring higher doses), gadolinium-enhanced CT is a recognized alternative in special clinical circumstances.

Question 8: All of the following dyes are water soluble except:

A. Myodil (Correct Answer)
B. Iohexol
C. Conray 420
D. Metrizamide

Explanation: ***Myodil*** - **Myodil** (Iophendylate) is an **oil-based** contrast medium previously used for myelography. - Due to its **oil-based nature**, it is not water-soluble and had to be removed after the procedure to prevent complications. *Iohexol* - **Iohexol** is a **non-ionic, water-soluble** contrast agent commonly used in various radiological procedures, including myelography. - Its water solubility allows for easy absorption and excretion from the body. *Conray 420* - **Conray 420** (Iothalamate meglumine) is an **ionic, water-soluble** contrast agent often used for angiography and urography. - It readily mixes with bodily fluids due to its water-soluble properties. *Metrizamide* - **Metrizamide** was an early **non-ionic, water-soluble** contrast agent specifically developed for myelography. - Although water-soluble, it had a higher incidence of neurotoxicity compared to newer agents like iohexol.

Question 9: Which of the following is a non-ionic contrast agent?

A. Amidotrizoate
B. Iothalamate
C. Ioxoglate
D. Iohexol (Correct Answer)

Explanation: ***Iohexol*** - **Iohexol** is a well-known example of a **non-ionic, low osmolar contrast agent**. It's widely used due to its lower incidence of adverse reactions compared to ionic agents. - Non-ionic contrast agents remain as **intact molecules** in solution and do not dissociate into charged ions, contributing to their lower osmolality and better tolerability. *Amidotrizoate* - **Amidotrizoate** (also known as diatrizoate) is an **ionic, high osmolar contrast agent**. It dissociates into two ions in solution. - Due to its high osmolality, it is associated with a higher risk of adverse effects, such as **nausea**, **vomiting**, and **nephrotoxicity**. *Iothalamate* - **Iothalamate** is another example of an **ionic, high osmolar contrast agent**. It also dissociates into charged ions when dissolved. - Its use has decreased significantly with the development of safer non-ionic alternatives due to its higher potential for **adverse drug reactions**. *Ioxoglate* - **Ioxoglate** is a **dimeric, ionic contrast agent**. Although it's ionic, it has a lower osmolality than monomeric ionic agents due to its dimeric structure. - Despite being dimeric, it still dissociates into ions, distinguishing it from truly non-ionic compounds like iohexol.

Question 10: To obtain adequate diagnostic imaging in a morbidly obese patient, what modification to X-ray technique is most important?

A. Increase MAS
B. Decrease KVP
C. Increase KVP (Correct Answer)
D. Decrease MAS

Explanation: ***Increase KVP*** - Increasing the **kilovoltage peak (KVP)** is essential for imaging morbidly obese patients because it increases the **penetrating power** of the X-ray beam, allowing adequate transmission through thick body tissues. - Higher KVP (typically 90-120 kVp range) ensures the X-ray beam can penetrate increased soft tissue thickness and reach the image receptor with sufficient intensity. - While higher KVP produces **longer scale (lower) contrast**, it is necessary for adequate **penetration** in obese patients - without sufficient KVP, the image would be underexposed and non-diagnostic. - In practice, both KVP and MAS are increased for obese patients, but **KVP increase is more critical** for penetration. *Increase MAS* - Increasing **milliampere-seconds (MAS)** increases the quantity of X-ray photons and image density (brightness), which is also helpful for obese patients. - However, MAS alone without adequate KVP cannot solve the penetration problem - the photons would still be too low energy to penetrate thick tissues effectively. - MAS increase without KVP increase would result in high patient dose with poor image quality. *Decrease KVP* - Decreasing KVP reduces **beam penetration**, which would be catastrophic for imaging an obese patient. - The X-ray beam would be absorbed by superficial tissues, resulting in a severely **underexposed** and non-diagnostic image. - While lower KVP produces higher contrast in theory, it is completely inappropriate for thick body parts. *Decrease MAS* - Decreasing MAS reduces the number of X-ray photons, resulting in an **underexposed, lighter** image. - This would make it even more difficult to obtain adequate imaging through increased body mass, resulting in a non-diagnostic radiograph with excessive quantum mottle.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free